
### [Orphanet:171895](http://www.orpha.net/ORDO/Orphanet_171895)
**Label:** Myeloid hemopathy

**Subclasses:** [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714) (Unclassified acute myeloid leukemia), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519) (Acute myeloid leukemia), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851) (Acute leukemia of ambiguous lineage), [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277) (Acute myeloid leukemia with recurrent genetic anomaly), [Orphanet:52688](http://www.orpha.net/ORDO/Orphanet_52688) (Myelodysplastic syndrome), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846) (Therapy related acute myeloid leukemia and myelodysplastic syndrome), 

**Corr. equiv. classes:** [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277), [Orphanet:52688](http://www.orpha.net/ORDO/Orphanet_52688), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846), [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851), 

**Class expressions from DL-Learner:**

- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 21.41%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 18.77%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 17.18%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 17.05%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 16.47%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 16.25%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 15.34%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 15.29%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 15.14%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 14.63%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 13.56%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 13.56%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 13.32%
- Thing 13.32%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 13.32%


